Piers Eaton

Braxia Scientific (BRAX.C) announced they will be conducting a randomized clinical trial that will involve giving patients multiple doses of psilocybin. Braxia says this is Canada’s first psilocybin trial…
Another busy week in the psychedelic sector, with many smaller companies not always covered here at Equity Guru making news. Let’s start with the biggest players though. Mind Medicine…
Predictmedix (PMED.C) announced they will be deploying four of their Safe Entry Stations to the Palm Tree Music Festival this Sunday in Westhampton Beach, NY. The Palm Tree Music…
Aurora Germany GmbH, a subsidiary of Aurora Cannabis (ACB.N), has successfully delivered their initial shipment of cannabis to France for their medical cannabis pilot program, set to begin serving…
Awakn Life Sciences (AWKN.NE) announced it has received ethical approval to conduct the first-ever study of the effects of ketamine on gambling addiction. Awakn has begun to recruit patients…
Mindset Pharma (MSET.C) announced they have filed a new patent with the US Patent and Trade Office (USPTO), extending its Family 4 compounds, a set of novel DMT/5-MeO-DMT analogs….
Mind Medicine (MNMD.Q, MMED.NE) announced that they have agreed to partner with Forian (FORA.Q), who provide evidence-based support for clinical and commercial decision making. Forian and MindMed will collaborate…
Plurilock Security (PLUR.V) announced they have received a $1.08 million USD purchase order from the US Air Force as part of the National Aeronautics and Space Administration’s (NASA) Solution…
Update: After reading my article (and only mine), OnlyFans reversed their decision, and will drop the planned ban. Disclaimer: If my mom or a future girlfriend finds this article,…
Score Media and Gaming (SCR.T) and Menkes Developments, alongside BentallGreenOak, announced today that they have entered into an agreement for theScore to lease an 80,000-square-foot space in the Waterfront…